StonvexLoading…
StonvexStonvexStonvexCore line items from CMRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $877.90M | $888.49M | $848.29M | $1.11B |
Operating Income | $456.19M | $489.70M | $594.97M | $662.25M |
Net Income | $364.57M | $319.92M | $385.75M | $554.96M |
EPS (Diluted) | $2.86 | $2.44 | $2.95 | $4.26 |
Total Assets | $3.86B | $5.15B | $5.29B | $4.90B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $519.85M | $656.88M | $710.61M | $718.05M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 120.58M | 119.95M | 118.37M | 122.30M |